Joseph K. Belanoff

2018

In 2018, Joseph K. Belanoff earned a total compensation of $6.3M as Chief Executive Officer and President at Corcept Therapeutics, a 48% increase compared to previous year.

Compensation breakdown

Bonus$477,750
Option Awards$5,157,075
Salary$679,792
Total$6,314,617

Belanoff received $5.2M in option awards, accounting for 82% of the total pay in 2018.

Belanoff also received $477.8K in bonus and $679.8K in salary.

Rankings

In 2018, Joseph K. Belanoff's compensation ranked 1,457th out of 14,244 executives tracked by ExecPay. In other words, Belanoff earned more than 89.8% of executives.

ClassificationRankingPercentile
All
1,457
out of 14,244
90th
Division
Manufacturing
509
out of 5,759
91st
Major group
Chemicals And Allied Products
160
out of 2,122
93rd
Industry group
Drugs
125
out of 1,811
93rd
Industry
Pharmaceutical Preparations
91
out of 1,385
93rd
Source: SEC filing on April 24, 2019.

Belanoff's colleagues

We found four more compensation records of executives who worked with Joseph K. Belanoff at Corcept Therapeutics in 2018.

2018

G Robb

Corcept Therapeutics

Chief Financial Officer

2018

Charles Robb

Corcept Therapeutics

Chief Financial Officer

2018

Sean Maduck

Corcept Therapeutics

Senior Vice President, Commercial

2018

Robert Fishman

Corcept Therapeutics

Chief Medical Officer

News

In-depth

You may also like